BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000;95:1431-8. [PMID: 10894575 DOI: 10.1111/j.1572-0241.2000.02074.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 186] [Article Influence: 7.9] [Reference Citation Analysis]
Number Citing Articles
1 Kanemitsu T, Uedo N, Ono T, Nimura S, Hasegawa R, Imamura K, Ohtsu K, Ono Y, Miyaoka M, Ueki T, Tanabe H, Ohta A, Iwashita A, Yao K. Magnifying endoscopy with narrow-band imaging for diagnosis of subtype of gastric intestinal metaplasia. J Gastroenterol Hepatol 2023;38:94-102. [PMID: 36268636 DOI: 10.1111/jgh.16034] [Reference Citation Analysis]
2 Vaes N, Idris M, Boesmans W, Alves MM, Melotte V. Nerves in gastrointestinal cancer: from mechanism to modulations. Nat Rev Gastroenterol Hepatol 2022;19:768-84. [PMID: 36056202 DOI: 10.1038/s41575-022-00669-9] [Reference Citation Analysis]
3 Hara D, Okamura T, Iwaya Y, Nagaya T, Ota H, Umemura T. Histopathologically defined intestinal metaplasia in lesser curvature of corpus prior to Helicobacter pylori eradication is a risk factor for gastric cancer development. Helicobacter 2022;27:e12934. [PMID: 36263778 DOI: 10.1111/hel.12934] [Reference Citation Analysis]
4 Gao R, Zhang X, Chen X, Chen X, Pan D, Jin L, Lin Y, Zheng H, Yu X, Chen X. Clinical and pathological analysis of intestinal metaplasia and intraepithelial neoplasia of gastric mucosa: intestinal metaplasia inhibits the progression of intraepithelial neoplasia.. [DOI: 10.21203/rs.3.rs-2011421/v1] [Reference Citation Analysis]
5 Na HK, Choi KD, Park YS, Kim HJ, Ahn JY, Lee JH, Jung KW, Kim DH, Song HJ, Lee GH, Jung HY. Endoscopic scoring system for gastric atrophy and intestinal metaplasia: correlation with OLGA and OLGIM staging: a single-center prospective pilot study in Korea. Scand J Gastroenterol 2022;57:1097-104. [PMID: 35387540 DOI: 10.1080/00365521.2022.2055974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hwang YJ, Choi Y, Kim N, Lee HS, Yoon H, Shin CM, Park YS, Lee DH. The Difference of Endoscopic and Histologic Improvements of Atrophic Gastritis and Intestinal Metaplasia After Helicobacter pylori Eradication. Dig Dis Sci 2022;67:3055-66. [PMID: 34365533 DOI: 10.1007/s10620-021-07146-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Oliveros_wilches R, Grillo-ardila CF, Vallejo-ortega M, Gil-parada F, Cardona-tobón M, Páramo-hernández D, Cuello-lacouture E, Rengifo-pardo A, Bedoya-urresta Á, Blanco-avellaneda C, Landazábal-bernal G, Vargas-rubio R, Pinilla-morales R, Facundo-navia G, Calderón-franco C, Villate-soto S, García-lópez A, Torres-castillo J, Medina-rojas Y, Alzate-granados J, Del Río-ospina L, Torres-amaya A, Pardo-turriago R. Guía de práctica clínica para la prevención primaria y secundaria y diagnóstico temprano de cáncer gástrico. Rev colomb cancerol 2022;26:39-96. [DOI: 10.35509/01239015.754] [Reference Citation Analysis]
8 Lerch JM, Pai RK, Brown I, Gill AJ, Jain D, Kővári B, Kushima R, Sheahan K, Slavik T, Srivastava A, Lauwers GY, Langner C. Subtyping intestinal metaplasia in patients with chronic atrophic gastritis: an interobserver variability study. Pathology 2022. [DOI: 10.1016/j.pathol.2021.12.288] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Lerch JM, Pai RK, Brown I, Gill AJ, Jain D, Kővári B, Kushima R, Sheahan K, Slavik T, Srivastava A, Lauwers GY, Langner C. Interobserver agreement of estimating the extent of intestinal metaplasia in patients with chronic atrophic gastritis. Virchows Arch 2021. [PMID: 34904185 DOI: 10.1007/s00428-021-03245-9] [Reference Citation Analysis]
10 Sáenz JB. Follow the Metaplasia: Characteristics and Oncogenic Implications of Metaplasia's Pattern of Spread Throughout the Stomach. Front Cell Dev Biol 2021;9:741574. [PMID: 34869328 DOI: 10.3389/fcell.2021.741574] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Wang JE, Kim SE, Lee BE, Park S, Hwang JH, Huang RJ. The risk of diffuse-type gastric cancer following diagnosis with gastric precancerous lesions: a systematic review and meta-analysis. Cancer Causes Control 2021. [PMID: 34797436 DOI: 10.1007/s10552-021-01522-1] [Reference Citation Analysis]
12 O'Connor A, Bowden A, Farrell E, Weininger J, Crowther S, McNamara D, Ridgway P, O'Morain C. Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body. Dig Dis Sci 2021;66:3470-5. [PMID: 33094451 DOI: 10.1007/s10620-020-06659-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Chen HY, Hu Y, Lu NH, Zhu Y. Caudal type homeoboxes as a driving force in Helicobacter pylori infection-induced gastric intestinal metaplasia. Gut Microbes 2020;12:1-12. [PMID: 33031021 DOI: 10.1080/19490976.2020.1809331] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Chapelle N, Péron M, Quénéhervé L, Bourget A, Leroy M, Touchefeu Y, Cauchin E, Coron E, Mosnier JF, Matysiak-Budnik T. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Clin Transl Gastroenterol 2020;11:e00237. [PMID: 33512802 DOI: 10.14309/ctg.0000000000000237] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
15 Păun I, Costin AI, Constantin VD, Lomaca I, Ianoşi NG, Socea B, Tutunaru CV, Zlatian OM, Ianoşi SL, Neagoe CD, Crafciuc AV, Stancu MI. Gastric cancer - histopathological correlations between tumor and non-tumor gastric mucosa changes. Rom J Morphol Embryol 2020;61:1129-41. [PMID: 34171062 DOI: 10.47162/RJME.61.4.15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Zhang R, Rabinovitch PS, Mattis AN, Lauwers GY, Choi WT. Gastric Intestinal Metaplasia in Mucosa Adjacent to Gastric Cancers Is Rarely Associated With the Aneuploidy That Is Characteristic of Gastric Dysplasia or Cancer. Am J Surg Pathol 2021. [PMID: 34091484 DOI: 10.1097/PAS.0000000000001764] [Reference Citation Analysis]
17 Pita I, Libânio D, Nunes PP. Diagnosis and Management of Epithelial Precancerous Conditions and Lesions in the Stomach. Curr Treat Options Gastro 2021;19:277-294. [DOI: 10.1007/s11938-021-00341-2] [Reference Citation Analysis]
18 Cho JH, Jeon SR, Jin SY, Park S. Standard vs magnifying narrow-band imaging endoscopy for diagnosis of Helicobacter pylori infection and gastric precancerous conditions. World J Gastroenterol 2021; 27(18): 2238-2250 [PMID: 34025076 DOI: 10.3748/wjg.v27.i18.2238] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Wei N, Zhou M, Lei S, Zhong Z, Shi R. A meta-analysis and systematic review on subtypes of gastric intestinal metaplasia and neoplasia risk. Cancer Cell Int 2021;21:173. [PMID: 33731114 DOI: 10.1186/s12935-021-01869-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
20 Koulis A, Busuttil RA, Boussioutas A. Premalignant lesions of the stomach and management of early neoplastic lesions. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00013-7] [Reference Citation Analysis]
21 Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterología y Hepatología (English Edition) 2021;44:67-86. [DOI: 10.1016/j.gastre.2020.08.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Dhingra R, Natov NS, Daaboul Y, Guelrud M, Cherukara A, Hung PF, Sterling MJ. Increased Risk of Progression to Gastric Adenocarcinoma in Patients with Non-dysplastic Gastric Intestinal Metaplasia Versus a Control Population. Dig Dis Sci 2020;65:3316-23. [PMID: 31916085 DOI: 10.1007/s10620-019-06031-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
23 Cubiella J, Pérez Aisa Á, Cuatrecasas M, Díez Redondo P, Fernández Esparrach G, Marín-Gabriel JC, Moreira L, Núñez H, Pardo López ML, Rodríguez de Santiago E, Rosón P, Sanz Anquela JM, Calvet X; en representación de la Asociación Española de Gastroenterología, la Sociedad Española de Endoscopia Digestiva y la Sociedad Española de Anatomía Patológica. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP. Gastroenterol Hepatol 2021;44:67-86. [PMID: 33252332 DOI: 10.1016/j.gastrohep.2020.08.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
24 Bulbuloglu E, Dagmura H, Daldal E, Deresoy A, Bakir H, Ozsoy U, Saglam AI, Demir O. Can Simple Tests Prior to Endoscopy Predict the OLGA Stage of Gastritis? Healthcare (Basel) 2020;8:E230. [PMID: 32722268 DOI: 10.3390/healthcare8030230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Ji R, Liu J, Zhang MM, Li YY, Zuo XL, Wang X, Li YQ. Optical enhancement imaging versus acetic acid for detecting gastric intestinal metaplasia: A randomized, comparative trial. Dig Liver Dis 2020;52:651-7. [PMID: 32265143 DOI: 10.1016/j.dld.2020.02.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Aydin M. Üst gastrointestinal sistem endoskopi uygulanan hastalarda intestinal metaplazi sıklığının araştırılması. Akademik Gastroenteroloji Dergisi 2020. [DOI: 10.17941/agd.729407] [Reference Citation Analysis]
27 Lam SK, Lau G. Novel treatment for gastric intestinal metaplasia, a precursor to cancer. JGH Open. 2020;4:569-573. [PMID: 32782940 DOI: 10.1002/jgh3.12318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
28 Yu X, Chen J, Zheng L, Song J, Lin R, Hou X. Quantitative Diagnosis of Atrophic Gastritis by Probe-Based Confocal Laser Endomicroscopy. Biomed Res Int 2020;2020:9847591. [PMID: 32190694 DOI: 10.1155/2020/9847591] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Tan MC, Mallepally N, Liu Y, El-Serag HB, Thrift AP. Demographic and Lifestyle Risk Factors for Gastric Intestinal Metaplasia Among US Veterans. Am J Gastroenterol 2020;115:381-7. [PMID: 31899705 DOI: 10.14309/ajg.0000000000000498] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
30 Shah SC, Gawron AJ, Mustafa RA, Piazuelo MB. Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice. Gastroenterology 2020;158:745-50. [PMID: 31887261 DOI: 10.1053/j.gastro.2019.12.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 8.7] [Reference Citation Analysis]
31 Gawron AJ, Shah SC, Altayar O, Davitkov P, Morgan D, Turner K, Mustafa RA. AGA Technical Review on Gastric Intestinal Metaplasia-Natural History and Clinical Outcomes. Gastroenterology 2020;158:705-731.e5. [PMID: 31816300 DOI: 10.1053/j.gastro.2019.12.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 16.0] [Reference Citation Analysis]
32 Lee G, Ahn S, Jeong M, Jang I. A Review of Recent Clinical Research about Banhasasim-tang Combined with Conventional Therapy on Atrophic Gastritis. J Int Korean Med 2019;40:1169-1178. [DOI: 10.22246/jikm.2019.40.6.1169] [Reference Citation Analysis]
33 Graham DY, Rugge M, Genta RM. Diagnosis: gastric intestinal metaplasia - what to do next? Curr Opin Gastroenterol 2019;35:535-43. [PMID: 31415250 DOI: 10.1097/MOG.0000000000000576] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
34 Wang K, Zhao XH, Liu J, Zhang R, Li JP. Nervous system and gastric cancer. Biochim Biophys Acta Rev Cancer 2020;1873:188313. [PMID: 31647986 DOI: 10.1016/j.bbcan.2019.188313] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
35 Koulis A, Buckle A, Boussioutas A. Premalignant lesions and gastric cancer: Current understanding. World J Gastrointest Oncol 2019; 11(9): 665-678 [PMID: 31558972 DOI: 10.4251/wjgo.v11.i9.665] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]
36 Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019;68:1545-75. [PMID: 31278206 DOI: 10.1136/gutjnl-2018-318126] [Cited by in Crossref: 203] [Cited by in F6Publishing: 184] [Article Influence: 50.8] [Reference Citation Analysis]
37 Quach DT, Hiyama T, Gotoda T. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World J Gastroenterol 2019; 25(27): 3546-3562 [PMID: 31367156 DOI: 10.3748/wjg.v25.i27.3546] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
38 Massironi S, Zilli A, Elvevi A, Invernizzi P. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmunity Reviews 2019;18:215-22. [DOI: 10.1016/j.autrev.2018.08.011] [Cited by in Crossref: 60] [Cited by in F6Publishing: 60] [Article Influence: 15.0] [Reference Citation Analysis]
39 Da B, Jani N, Gupta N, Jayaram P, Kankotia R, Yao Yu C, Dinis-Ribeiro M, Buxbaum J. High-risk symptoms do not predict gastric cancer precursors. Helicobacter 2019;24:e12548. [PMID: 30412322 DOI: 10.1111/hel.12548] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
40 Gibson JA, Odze RD. Tissue Sampling, Specimen Handling, and Laboratory Processing. Clinical Gastrointestinal Endoscopy 2019. [DOI: 10.1016/b978-0-323-41509-5.00005-0] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Kinoshita H, Hayakawa Y, Konishi M, Hata M, Tsuboi M, Hayata Y, Hikiba Y, Ihara S, Nakagawa H, Ikenoue T, Ushiku T, Fukayama M, Hirata Y, Koike K. Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium. J Pathol. 2019;247:35-47. [PMID: 30168144 DOI: 10.1002/path.5163] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
42 Wang L, Xu J, Xia Y, Yin K, Li Z, Li B, Wang W, Xu H, Yang L, Xu Z. Muscarinic acetylcholine receptor 3 mediates vagus nerve-induced gastric cancer. Oncogenesis 2018;7:88. [PMID: 30459304 DOI: 10.1038/s41389-018-0099-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
43 Fitzgibbons PL. Histochemistry in the diagnosis of non-neoplastic gastrointestinal disorders. Semin Diagn Pathol 2018;35:370-80. [PMID: 30366790 DOI: 10.1053/j.semdp.2018.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
44 Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology 2018;155:648-60. [PMID: 29778607 DOI: 10.1053/j.gastro.2018.05.026] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 15.0] [Reference Citation Analysis]
45 Shao L, Li P, Ye J, Chen J, Han Y, Cai J, Lu X. Risk of gastric cancer among patients with gastric intestinal metaplasia. Int J Cancer. 2018;. [PMID: 29707766 DOI: 10.1002/ijc.31571] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
46 Sobrino-cossío S, Abdo Francis J, Emura F, Galvis-garcía E, Márquez Rocha M, Mateos-pérez G, González-sánchez C, Uedo N. Efficacy of narrow-band imaging for detecting intestinal metaplasia in adult patients with symptoms of dyspepsia. Revista de Gastroenterología de México (English Edition) 2018;83:245-252. [DOI: 10.1016/j.rgmxen.2018.03.009] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
47 Sobrino-cossío S, Abdo Francis J, Emura F, Galvis-garcía E, Márquez Rocha M, Mateos-pérez G, González-sánchez C, Uedo N. La eficacia de la imagen de banda estrecha para la detección de metaplasia intestinal en pacientes adultos con síntomas de dispepsia. Revista de Gastroenterología de México 2018;83:245-52. [DOI: 10.1016/j.rgmx.2017.08.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
48 Zhang L, Liu Y, You P, Feng G. Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up. Scand J Gastroenterol 2018;53:843-8. [PMID: 29911441 DOI: 10.1080/00365521.2018.1477987] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
49 Quach DT, Le HM, Nguyen TS, Hiyama T. The Distribution of Incomplete Gastric Intestinal Metaplasia (GIM) Subtype among Biopsy Sites according to the Updated Sydney System and Its Association with GIM Extension. Gastroenterol Res Pract. 2018;2018:4938730. [PMID: 29853861 DOI: 10.1155/2018/4938730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
50 Sáenz JB, Mills JC. Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 2018;15:257-73. [PMID: 29463907 DOI: 10.1038/nrgastro.2018.5] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 13.8] [Reference Citation Analysis]
51 Quach DT, Hiyama T. Letter: extensive intestinal metaplasia is associated with the presence of incomplete intestinal metaplasia subtype and could be an easier marker for high risk of gastric cancer. Aliment Pharmacol Ther 2018;47:1045-6. [PMID: 29512911 DOI: 10.1111/apt.14553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
52 Sepulveda AR, J. Del Portillo A. Molecular Basis of Diseases of the Gastrointestinal Tract. Molecular Pathology 2018. [DOI: 10.1016/b978-0-12-802761-5.00019-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
53 Mahachai V, Vilaichone RK, Pittayanon R, Rojborwonwitaya J, Leelakusolvong S, Maneerattanaporn M, Chotivitayatarakorn P, Treeprasertsuk S, Kositchaiwat C, Pisespongsa P, Mairiang P, Rani A, Leow A, Mya SM, Lee YC, Vannarath S, Rasachak B, Chakravuth O, Aung MM, Ang TL, Sollano JD, Trong Quach D, Sansak I, Wiwattanachang O, Harnsomburana P, Syam AF, Yamaoka Y, Fock KM, Goh KL, Sugano K, Graham D. Helicobacter pylori management in ASEAN: The Bangkok consensus report. J Gastroenterol Hepatol 2018;33:37-56. [PMID: 28762251 DOI: 10.1111/jgh.13911] [Cited by in Crossref: 69] [Cited by in F6Publishing: 67] [Article Influence: 13.8] [Reference Citation Analysis]
54 Shibata W, Sue S, Tsumura S, Ishii Y, Sato T, Kameta E, Sugimori M, Yamada H, Kaneko H, Sasaki T, Ishii T, Tamura T, Kondo M, Maeda S. Helicobacter-induced gastric inflammation alters the properties of gastric tissue stem/progenitor cells. BMC Gastroenterol 2017;17:145. [PMID: 29212456 DOI: 10.1186/s12876-017-0706-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
55 Kinoshita H, Hayakawa Y, Koike K. Metaplasia in the Stomach-Precursor of Gastric Cancer? Int J Mol Sci. 2017;18:pii: E2063. [PMID: 28953255 DOI: 10.3390/ijms18102063] [Cited by in Crossref: 32] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
56 Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Koike K. Association between gastric cancer and the Kyoto classification of gastritis. J Gastroenterol Hepatol 2017;32:1581-6. [PMID: 28217843 DOI: 10.1111/jgh.13764] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
57 Cheng HC, Tsai YC, Yang HB, Yeh YC, Chang WL, Kuo HY, Lu CC, Sheu BS. The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia. Helicobacter 2017;22. [PMID: 28326664 DOI: 10.1111/hel.12385] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
58 Genta RM, Turner KO, Sonnenberg A. Demographic and socioeconomic influences on Helicobacter pylori gastritis and its pre-neoplastic lesions amongst US residents. Aliment Pharmacol Ther 2017;46:322-30. [PMID: 28547755 DOI: 10.1111/apt.14162] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
59 Smolka AJ, Schubert ML. Helicobacter pylori-Induced Changes in Gastric Acid Secretion and Upper Gastrointestinal Disease. Curr Top Microbiol Immunol 2017;400:227-52. [PMID: 28124156 DOI: 10.1007/978-3-319-50520-6_10] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
60 Sheu BS, Wu MS, Chiu CT, Lo JC, Wu DC, Liou JM, Wu CY, Cheng HC, Lee YC, Hsu PI, Chang CC, Chang WL, Lin JT. Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale. Helicobacter 2017;22. [PMID: 28066960 DOI: 10.1111/hel.12368] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 8.5] [Reference Citation Analysis]
61 Hayakawa Y, Sethi N, Sepulveda AR, Bass AJ, Wang TC. Oesophageal adenocarcinoma and gastric cancer: should we mind the gap? Nat Rev Cancer. 2016;16:305-318. [PMID: 27112208 DOI: 10.1038/nrc.2016.24] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 12.8] [Reference Citation Analysis]
62 Yantiss RK, Odze RD. Neoplastic precursor lesions of the upper gastrointestinal tract. Diagnostic Histopathology 2017;23:43-61. [DOI: 10.1016/j.mpdhp.2017.03.005] [Reference Citation Analysis]
63 Song KH, Hwang JA, Kim SM, Ko HS, Kang MK, Ryu KH, Koo HS, Lee TH, Huh KC, Choi YW, Kang YW. Acetic acid chromoendoscopy for determining the extent of gastric intestinal metaplasia. Gastrointest Endosc 2017;85:349-56. [PMID: 27515128 DOI: 10.1016/j.gie.2016.07.064] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
64 Rabben HL, Zhao CM, Hayakawa Y, Wang TC, Chen D. Vagotomy and Gastric Tumorigenesis. Curr Neuropharmacol. 2016;14:967-972. [PMID: 26791481 DOI: 10.2174/1570159x14666160121114854] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
65 Yoon H, Kim N, Shin CM, Lee HS, Kim BK, Kang GH, Kim JM, Kim JS, Lee DH, Jung HC. Risk Factors for Metachronous Gastric Neoplasms in Patients Who Underwent Endoscopic Resection of a Gastric Neoplasm. Gut Liver 2016;10:228-36. [PMID: 26087797 DOI: 10.5009/gnl14472] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
66 Uzzan M, Ko HM, Mehandru S, Cunningham-Rundles C. Gastrointestinal Disorders Associated with Common Variable Immune Deficiency (CVID) and Chronic Granulomatous Disease (CGD). Curr Gastroenterol Rep 2016;18:17. [PMID: 26951230 DOI: 10.1007/s11894-016-0491-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 8.7] [Reference Citation Analysis]
67 Kinsinger LA, Garber JC, Whipple O. A Review of Sleeve Gastrectomy Specimen Histopathology. The American Surgeon 2016;82:1101-4. [DOI: 10.1177/000313481608201126] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
68 Shichijo S, Hirata Y, Niikura R, Hayakawa Y, Yamada A, Ushiku T, Fukayama M, Koike K. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointest Endosc 2016;84:618-24. [PMID: 26995689 DOI: 10.1016/j.gie.2016.03.791] [Cited by in Crossref: 124] [Cited by in F6Publishing: 119] [Article Influence: 17.7] [Reference Citation Analysis]
69 Feng F, Tian Y, Guo M, Liu S, Xu G, Liu Z, Zheng G, Lian X, Fan D, Zhang H. Comparison of clinicopathological features and prognosis of gastric cancer located in the lesser and greater curve. Clin Transl Oncol 2017;19:457-63. [PMID: 27663247 DOI: 10.1007/s12094-016-1549-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
70 Li D, Bautista MC, Jiang SF, Daryani P, Brackett M, Armstrong MA, Hung YY, Postlethwaite D, Ladabaum U. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study. Am J Gastroenterol 2016;111:1104-13. [PMID: 27185078 DOI: 10.1038/ajg.2016.188] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 11.4] [Reference Citation Analysis]
71 Rugge M, Genta RM, Graham DY, Di Mario F, Vaz Coelho LG, Kim N, Malfertheiner P, Sugano K, Tsukanov V, Correa P. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut 2016;65:721-5. [PMID: 26927528 DOI: 10.1136/gutjnl-2015-310846] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
72 González CA, Sanz-Anquela JM, Companioni O, Bonet C, Berdasco M, López C, Mendoza J, Martín-Arranz MD, Rey E, Poves E, Espinosa L, Barrio J, Torres MÁ, Cuatrecasas M, Elizalde I, Bujanda L, Garmendia M, Ferrández Á, Muñoz G, Andreu V, Paules MJ, Lario S, Ramírez MJ, Gisbert JP; Study group. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study. J Gastroenterol Hepatol 2016;31:953-8. [PMID: 26630310 DOI: 10.1111/jgh.13249] [Cited by in Crossref: 70] [Cited by in F6Publishing: 68] [Article Influence: 10.0] [Reference Citation Analysis]
73 Zhou Y, Li HY, Zhang JJ, Chen XY, Ge ZZ, Li XB. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J Gastroenterol 2016; 22(13): 3670-3678 [PMID: 27053859 DOI: 10.3748/wjg.v22.i13.3670] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
74 Uno K, Iijima K, Shimosegawa T. Gastric cancer development after the successful eradication of Helicobacter pyloriWorld J Gastrointest Oncol 2016; 8(3): 271-281 [PMID: 26989462 DOI: 10.4251/wjgo.v8.i3.271] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
75 Lamarque D. Dysplasie de bas grade sur une biopsie : que faire ? Acta Endosc 2016;46:187-189. [DOI: 10.1007/s10190-016-0546-1] [Reference Citation Analysis]
76 Liu KSH, Wong IOL, Leung WK. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance. World J Gastroenterol 2016; 22(3): 1311-1320 [PMID: 26811668 DOI: 10.3748/wjg.v22.i3.1311] [Cited by in CrossRef: 45] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
77 Yoon JH, Choi SS, Kim O, Choi WS, Park YK, Nam SW, Lee JY, Park WS. Inactivation of NKX6.3 in the stomach leads to abnormal expression of CDX2 and SOX2 required for gastric-to-intestinal transdifferentiation. Mod Pathol. 2016;29:194-208. [PMID: 26743476 DOI: 10.1038/modpathol.2015.150] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
78 Yoon H, Kim N. Diagnosis and management of high risk group for gastric cancer. Gut Liver. 2015;9:5-17. [PMID: 25547086 DOI: 10.5009/gnl14118] [Cited by in Crossref: 145] [Cited by in F6Publishing: 157] [Article Influence: 18.1] [Reference Citation Analysis]
79 Shichijo S, Hirata Y, Sakitani K, Yamamoto S, Serizawa T, Niikura R, Watabe H, Yoshida S, Yamada A, Yamaji Y, Ushiku T, Fukayama M, Koike K. Distribution of intestinal metaplasia as a predictor of gastric cancer development. J Gastroenterol Hepatol 2015;30:1260-4. [PMID: 25777777 DOI: 10.1111/jgh.12946] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
80 Evans JA, Chandrasekhara V, Chathadi KV, Decker GA, Early DS, Fisher DA, Foley K, Hwang JH, Jue TL, Lightdale JR, Pasha SF, Sharaf R, Shergill AK, Cash BD, DeWitt JM; ASGE Standards of Practice Committee. The role of endoscopy in the management of premalignant and malignant conditions of the stomach. Gastrointest Endosc 2015;82:1-8. [PMID: 25935705 DOI: 10.1016/j.gie.2015.03.1967] [Cited by in Crossref: 156] [Cited by in F6Publishing: 147] [Article Influence: 19.5] [Reference Citation Analysis]
81 Genta RM, Sonnenberg A. Characteristics of the gastric mucosa in patients with intestinal metaplasia. Am J Surg Pathol. 2015;39:700-704. [PMID: 25602799 DOI: 10.1097/pas.0000000000000384] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
82 Bornschein J, Dingwerth A, Selgrad M, Venerito M, Stuebs P, Frauenschlaeger K, Achilleos A, Roessner A, Malfertheiner P. Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions. Eur J Gastroenterol Hepatol 2015;27:492-500. [PMID: 25822856 DOI: 10.1097/MEG.0000000000000299] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
83 Liu T, Zheng H, Gong W, Chen C, Jiang B. The accuracy of confocal laser endomicroscopy, narrow band imaging, and chromoendoscopy for the detection of atrophic gastritis. J Clin Gastroenterol 2015;49:379-86. [PMID: 25485568 DOI: 10.1097/MCG.0000000000000164] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
84 Zhao CM, Hayakawa Y, Kodama Y, Muthupalani S, Westphalen CB, Andersen GT, Flatberg A, Johannessen H, Friedman RA, Renz BW, Sandvik AK, Beisvag V, Tomita H, Hara A, Quante M, Li Z, Gershon MD, Kaneko K, Fox JG, Wang TC, Chen D. Denervation suppresses gastric tumorigenesis. Sci Transl Med. 2014;6:250ra115. [PMID: 25143365 DOI: 10.1126/scitranslmed.3009569] [Cited by in Crossref: 329] [Cited by in F6Publishing: 349] [Article Influence: 41.1] [Reference Citation Analysis]
85 Bellizzi AM, Hornick JL. The stomach. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.026] [Reference Citation Analysis]
86 Martínez-Galindo MG, Zamarripa-Dorsey F, Carmona-Castañeda A, Angeles-Labra A, Peñavera-Hernández R, Ugarte-Briones C, Blanco-Vela CI. Histopathologic characteristics of gastric adenocarcinoma in Mexican patients: a 10-year experience at the Hospital Juárez of Mexico. Rev Gastroenterol Mex 2015;80:21-6. [PMID: 25747884 DOI: 10.1016/j.rgmx.2014.11.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
87 Martínez-galindo M, Zamarripa-dorsey F, Carmona-castañeda A, Angeles-labra A, Peñavera-hernández R, Ugarte-briones C, Blanco-vela C. Histopathologic characteristics of gastric adenocarcinoma in Mexican patients: A 10-year experience at the Hospital Juárez de México. Revista de Gastroenterología de México (English Edition) 2015;80:21-26. [DOI: 10.1016/j.rgmxen.2015.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
88 Lahner E, Zullo A, Hassan C, Perri F, Dinis-Ribeiro M, Esposito G, Di Giulio E, Buscarini E, Bianco MA, De Boni M, Annibale B; MAG-Study Group. Detection of gastric precancerous conditions in daily clinical practice: a nationwide survey. Helicobacter 2014;19:417-24. [PMID: 25231208 DOI: 10.1111/hel.12149] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
89 Rugge M, Capelle LG, Fassan M. Individual risk stratification of gastric cancer: evolving concepts and their impact on clinical practice. Best Pract Res Clin Gastroenterol 2014;28:1043-53. [PMID: 25439070 DOI: 10.1016/j.bpg.2014.09.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
90 Panteris V, Nikolopoulou S, Lountou A, Triantafillidis JK. Diagnostic capabilities of high-definition white light endoscopy for the diagnosis of gastric intestinal metaplasia and correlation with histologic and clinical data. Eur J Gastroenterol Hepatol 2014;26:594-601. [PMID: 24743505 DOI: 10.1097/MEG.0000000000000097] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
91 De Petris G, Dhungel BM, Chen L, Chang YH. Gastric adenocarcinoma in common variable immunodeficiency: features of cancer and associated gastritis may be characteristic of the condition. Int J Surg Pathol 2014;22:600-6. [PMID: 24788529 DOI: 10.1177/1066896914532540] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
92 Bornschein J, Malfertheiner P. Helicobacter pylori and gastric cancer. Dig Dis 2014;32:249-64. [PMID: 24732191 DOI: 10.1159/000357858] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
93 Marques-Silva L, Areia M, Elvas L, Dinis-Ribeiro M. Prevalence of gastric precancerous conditions: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2014;26:378-87. [PMID: 24569821 DOI: 10.1097/MEG.0000000000000065] [Cited by in Crossref: 71] [Cited by in F6Publishing: 72] [Article Influence: 7.9] [Reference Citation Analysis]
94 Polydorides AD. Pathology and differential diagnosis of chronic, noninfectious gastritis. Seminars in Diagnostic Pathology 2014;31:114-23. [DOI: 10.1053/j.semdp.2014.02.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
95 Isajevs S, Liepniece-Karele I, Janciauskas D, Moisejevs G, Putnins V, Funka K, Kikuste I, Vanags A, Tolmanis I, Leja M. Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch. 2014;464:403-407. [PMID: 24477629 DOI: 10.1007/s00428-014-1544-3] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
96 Zhou Z, Liu H, Gu G, Wang G, Wu W, Zhang C, Ren J. Immunoproteomic to identify antigens in the intestinal mucosa of Crohn's disease patients. PLoS One 2013;8:e81662. [PMID: 24358121 DOI: 10.1371/journal.pone.0081662] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
97 O’Connor A, McNamara D, O’Moráin CA. Surveillance of gastric intestinal metaplasia for the prevention of gastric cancer. Cochrane Database Syst Rev. 2013;9:CD009322. [PMID: 24062262 DOI: 10.1002/14651858.cd009322.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
98 Marcos-pinto R, Dinis-ribeiro M, Carneiro F, Wen X, Lopes C, Figueiredo C, Machado JC, Ferreira RM, Reis CA, Canedo P, Durães C, Ferreira J, Pedroto I, Areias J. First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile. Virchows Arch 2013;463:391-9. [DOI: 10.1007/s00428-013-1458-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
99 Savarino E, Corbo M, Dulbecco P, Gemignani L, Giambruno E, Mastracci L, Grillo F, Savarino V. Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia. World J Gastroenterol 2013; 19(17): 2668-2675 [PMID: 23674874 DOI: 10.3748/wjg.v19.i17.2668] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
100 Quach DT, Le HM, Hiyama T, Nguyen OT, Nguyen TS, Uemura N. Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia. Helicobacter 2013;18:151-7. [PMID: 23167960 DOI: 10.1111/hel.12027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
101 Rugge M, Capelle LG, Cappellesso R, Nitti D, Kuipers EJ. Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol 2013;27:205-23. [PMID: 23809241 DOI: 10.1016/j.bpg.2012.12.007] [Cited by in Crossref: 79] [Cited by in F6Publishing: 71] [Article Influence: 7.9] [Reference Citation Analysis]
102 González CA, Sanz-Anquela JM, Gisbert JP, Correa P. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence. Int J Cancer. 2013;133:1023-1032. [PMID: 23280711 DOI: 10.1002/ijc.28003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 7.1] [Reference Citation Analysis]
103 Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 2013;37:375-82. [PMID: 23216458 DOI: 10.1111/apt.12177] [Cited by in Crossref: 122] [Cited by in F6Publishing: 126] [Article Influence: 12.2] [Reference Citation Analysis]
104 Lim JH, Kim N, Lee HS, Choe G, Jo SY, Chon I, Choi C, Yoon H, Shin CM, Park YS, Lee DH, Jung HC. Correlation between Endoscopic and Histological Diagnoses of Gastric Intestinal Metaplasia. Gut Liver. 2013;7:41-50. [PMID: 23423616 DOI: 10.5009/gnl.2013.7.1.41] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
105 Bang BW, Kim HG. Endoscopic Classification of Intestinal Metaplasia. Korean J Helicobacter Up Gastrointest Res 2013;13:78. [DOI: 10.7704/kjhugr.2013.13.2.78] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
106 Haneda M, Kato M, Ishigaki S, Suzuki M, Takahashi M, Nakagawa M, Ono S, Mori Y, Mabe K, Nakagawa S, Kudo T, Shimizu Y, Asaka M. Identification of a high risk gastric cancer group using serum pepsinogen after successful eradication of Helicobacter pylori. J Gastroenterol Hepatol 2013;28:78-83. [PMID: 23034090 DOI: 10.1111/j.1440-1746.2012.07285.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
107 Verdalet-Olmedo M, Sampieri CL, Morales-Romero J, Guevara HML, Machorro-Castaño &M, León-Córdoba K. Omission of breakfast and risk of gastric cancer in Mexico. World J Gastrointest Oncol 2012; 4(11): 223-229 [PMID: 23444276 DOI: 10.4251/wjgo.v4.i11.223] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
108 Lamarque D. Faut-il surveiller la métaplasie intestinale et la dysplasie dans l’estomac ? Acta Endosc 2012;42:257-260. [DOI: 10.1007/s10190-012-0281-1] [Reference Citation Analysis]
109 Leja M, Wex T, Malfertheiner P. Markers for gastric cancer premalignant lesions: where do we go? Dig Dis 2012;30:268-76. [PMID: 22722551 DOI: 10.1159/000336990] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
110 Kanzaki H, Uedo N, Ishihara R, Nagai K, Matsui F, Ohta T, Hanafusa M, Hanaoka N, Takeuchi Y, Higashino K, Iishi H, Tomita Y, Tatsuta M, Yamamoto K. Comprehensive investigation of areae gastricae pattern in gastric corpus using magnifying narrow band imaging endoscopy in patients with chronic atrophic fundic gastritis. Helicobacter 2012;17:224-31. [PMID: 22515361 DOI: 10.1111/j.1523-5378.2012.00938.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
111 Marcos-Pinto R, Carneiro F, Dinis-Ribeiro M, Wen X, Lopes C, Figueiredo C, Machado JC, Ferreira RM, Reis CA, Ferreira J, Pedroto I, Areias J. First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment Pharmacol Ther 2012;35:1451-9. [PMID: 22548492 DOI: 10.1111/j.1365-2036.2012.05111.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
112 Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: A critical reappraisal. World J Gastroenterol 2012; 18(12): 1279-1285 [PMID: 22493541 DOI: 10.3748/wjg.v18.i12.1279] [Cited by in CrossRef: 88] [Cited by in F6Publishing: 95] [Article Influence: 8.0] [Reference Citation Analysis]
113 Zullo A, Hassan C, Romiti A, Giusto M, Guerriero C, Lorenzetti R, Campo SM, Tomao S. Follow-up of intestinal metaplasia in the stomach: When, how and why. World J Gastrointest Oncol 2012; 4(3): 30-36 [PMID: 22468181 DOI: 10.4251/wjgo.v4.i3.30] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 74] [Article Influence: 6.1] [Reference Citation Analysis]
114 Lee BH, Kim N, Lee HS, Kang JM, Park HK, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS. The Role of CDX2 in Intestinal Metaplasia Evaluated Using Immunohistochemistry. Gut Liver 2012;6:71-7. [PMID: 22375174 DOI: 10.5009/gnl.2012.6.1.71] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
115 Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O'Connor A, Pereira C, Pimentel-Nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-Budnik T, Megraud F, Miki K, O'Morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; European Society of Gastrointestinal Endoscopy, European Helicobacter Study Group, European Society of Pathology, Sociedade Portuguesa de Endoscopia Digestiva. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74-94. [PMID: 22198778 DOI: 10.1055/s-0031-1291491] [Cited by in Crossref: 436] [Cited by in F6Publishing: 422] [Article Influence: 39.6] [Reference Citation Analysis]
116 Dinis-ribeiro M, Areia M, de Vries AC, Marcos-pinto R, Monteiro-soares M, O’connor A, Pereira C, Pimentel-nunes P, Correia R, Ensari A, Dumonceau JM, Machado JC, Macedo G, Malfertheiner P, Matysiak-budnik T, Megraud F, Miki K, O’morain C, Peek RM, Ponchon T, Ristimaki A, Rembacken B, Carneiro F, Kuipers EJ; on behalf of MAPS Participants. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch 2012;460:19-46. [DOI: 10.1007/s00428-011-1177-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 91] [Article Influence: 4.9] [Reference Citation Analysis]
117 Zheng L, Weng M, Qi M, Qi T, Tong L, Hou X, Tong Q. Aberrant expression of intelectin-1 in gastric cancer: its relationship with clinicopathological features and prognosis. J Cancer Res Clin Oncol 2012;138:163-72. [PMID: 22083213 DOI: 10.1007/s00432-011-1088-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
118 Rugge M, Fassan M, Pizzi M, Farinati F, Sturniolo GC, Plebani M, Graham DY. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterol 2011; 17(41): 4596-4601 [PMID: 22147965 DOI: 10.3748/wjg.v17.i41.4596] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 91] [Article Influence: 7.4] [Reference Citation Analysis]
119 Sakitani K, Hirata Y, Watabe H, Yamada A, Sugimoto T, Yamaji Y, Yoshida H, Maeda S, Omata M, Koike K. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J Gastroenterol Hepatol 2011;26:1570-5. [PMID: 21575058 DOI: 10.1111/j.1440-1746.2011.06767.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
120 Bornschein J, Malfertheiner P. Gastric carcinogenesis. Langenbecks Arch Surg. 2011;396:729-742. [PMID: 21611816 DOI: 10.1007/s00423-011-0810-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
121 Lee H, Min BH, Lee JH, Son HJ, Kim JJ, Rhee JC, Kim S, Rhee PL. Survival outcome associated with the screening interval for gastric cancer in Korea. Digestion 2011;84:142-8. [PMID: 21525769 DOI: 10.1159/000326857] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
122 Rugge M, Fassan M, Pizzi M, Pennelli G, Nitti D, Farinati F. Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. Hum Pathol. 2011;42:1539-1544. [PMID: 21481917 DOI: 10.1016/j.humpath.2010.12.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
123 Rugge M, Pennelli G, Pilozzi E, Fassan M, Ingravallo G, Russo VM, Di Mario F; Gruppo Italiano Patologi Apparato Digerente (GIPAD), Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Gastritis: the histology report. Dig Liver Dis 2011;43 Suppl 4:S373-84. [PMID: 21459343 DOI: 10.1016/S1590-8658(11)60593-8] [Cited by in Crossref: 83] [Cited by in F6Publishing: 90] [Article Influence: 6.9] [Reference Citation Analysis]
124 Kawamura M, Abe S, Oikawa K, Terai S, Saito M, Shibuya D, Kato K, Shimada T, Uedo N, Masuda T. Topographic differences in gastric micromucosal patterns observed by magnifying endoscopy with narrow band imaging. J Gastroenterol Hepatol 2011;26:477-83. [PMID: 21155881 DOI: 10.1111/j.1440-1746.2010.06527.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
125 Rugge M, Fassan M, Farinati F, Genta RM. The war of the worlds: metaplastic versus nonmetaplastic atrophic gastritis. Gastrointest Endosc 2011;73:411-2; author reply 412-3. [PMID: 21295657 DOI: 10.1016/j.gie.2010.06.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
126 Bornschein J, Selgrad M, Warnecke M, Kuester D, Wex T, Malfertheiner P. H. pylori infection is a key risk factor for proximal gastric cancer. Dig Dis Sci 2010;55:3124-31. [PMID: 20668939 DOI: 10.1007/s10620-010-1351-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
127 de Vries AC, Haringsma J, de Vries RA, Ter Borg F, van Grieken NC, Meijer GA, van Dekken H, Kuipers EJ. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter 2010;15:259-64. [PMID: 20633186 DOI: 10.1111/j.1523-5378.2010.00760.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
128 Zheng L, Pu J, Jiang G, Weng M, He J, Mei H, Hou X, Tong Q. Abnormal expression of early growth response 1 in gastric cancer: association with tumor invasion, metastasis and heparanase transcription. Pathol Int 2010;60:268-77. [PMID: 20403028 DOI: 10.1111/j.1440-1827.2010.02512.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
129 Lahner E, Bernardini G, Santucci A, Annibale B. Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics. 2010;7:239-248. [PMID: 20377390 DOI: 10.1586/epr.10.5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
130 Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, van Dekken H, Meijer J, van Grieken NC, Kuipers EJ. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010;71:1150-8. [PMID: 20381801 DOI: 10.1016/j.gie.2009.12.029] [Cited by in Crossref: 297] [Cited by in F6Publishing: 317] [Article Influence: 22.8] [Reference Citation Analysis]
131 Hassan C, Zullo A, Di Giulio E, Annibale B, Lahner E, De Francesco V, Ierardi E. Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia. Helicobacter 2010;15:221-6. [PMID: 20557364 DOI: 10.1111/j.1523-5378.2010.00752.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
132 Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010;105:493-8. [PMID: 20203636 DOI: 10.1038/ajg.2009.728] [Cited by in Crossref: 228] [Cited by in F6Publishing: 240] [Article Influence: 17.5] [Reference Citation Analysis]
133 Sepulveda AR, Lynch JP. Genetic Instability and Chronic Inflammation in Gastrointestinal Cancers. Cancer Genome and Tumor Microenvironment 2010. [DOI: 10.1007/978-1-4419-0711-0_16] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
134 A. Abrams J, Wang TC. Adenocarcinoma and Other Tumors of the Stomach. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00054-8] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
135 Zheng L, Weng M, He J, Yang X, Jiang G, Tong Q. Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis. Virchows Arch 2010;456:53-63. [PMID: 19967544 DOI: 10.1007/s00428-009-0861-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
136 Zheng L, Weng M, He J, Yang X, Jiang G, Tong Q. Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis. Virchows Arch 2010;456:53-63. [DOI: 10.1007/s00428-009-0861-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
137 Sun Y, Li Z, Feng G, Li J. Long-term follow-up study on gastric intestinal metaplasia subtype and its relation to expression of P53, Bcl-2 and PCNA. Chin J Cancer Res 2009;21:272-277. [DOI: 10.1007/s11670-009-0272-8] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
138 Capelle LG, de Vries AC, Haringsma J, Steyerberg EW, Looman CW, Nagtzaam NM, van Dekken H, ter Borg F, de Vries RA, Kuipers EJ. Serum levels of leptin as marker for patients at high risk of gastric cancer. Helicobacter 2009;14:596-604. [PMID: 19889078 DOI: 10.1111/j.1523-5378.2009.00728.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
139 Genta RM. In praise of folly: the Erasmus score for intestinal metaplasia. Gastrointest Endosc 2009;70:26-8. [PMID: 19559831 DOI: 10.1016/j.gie.2008.10.031] [Reference Citation Analysis]
140 de Vries AC, Haringsma J, de Vries RA, ter Borg F, Nagtzaam NM, Steyerberg EW, van Dekken H, Kuipers EJ. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice. Gastrointest Endosc 2009;70:18-25. [PMID: 19249770 DOI: 10.1016/j.gie.2008.08.041] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
141 Kim CG, Choi IJ, Lee JY, Cho SJ, Nam BH, Kook MC, Hong EK, Kim YW. Biopsy site for detecting Helicobacter pylori infection in patients with gastric cancer. J Gastroenterol Hepatol 2009;24:469-74. [PMID: 19067779 DOI: 10.1111/j.1440-1746.2008.05679.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
142 Sepulveda AR, Aisner DL. Molecular Basis of Diseases of the Gastrointestinal Tract. Molecular Pathology 2009. [DOI: 10.1016/b978-0-12-374419-7.00019-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
143 Akiyama J, Uemura N. Intestinal metaplasia subtype and gastric cancer risk. J Gastroenterol Hepatol 2009;24:4-6. [PMID: 19196392 DOI: 10.1111/j.1440-1746.2008.05736.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
144 Lash RH, Lauwers GY, Odze RD, Genta RM. Inflammatory Disorders of the Stomach. Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas 2009. [DOI: 10.1016/b978-141604059-0.50015-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
145 Yantiss RK, Odze RD. Neoplastic precursor lesions of the upper gastrointestinal tract. Diagnostic Histopathology 2008;14:437-52. [DOI: 10.1016/j.mpdhp.2008.07.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
146 Rugge M, Correa P, Di Mario F, El-Omar E, Fiocca R, Geboes K, Genta RM, Graham DY, Hattori T, Malfertheiner P, Nakajima S, Sipponen P, Sung J, Weinstein W, Vieth M. OLGA staging for gastritis: a tutorial. Dig Liver Dis 2008;40:650-8. [PMID: 18424244 DOI: 10.1016/j.dld.2008.02.030] [Cited by in Crossref: 210] [Cited by in F6Publishing: 210] [Article Influence: 14.0] [Reference Citation Analysis]
147 Mastracci L, Bruno S, Spaggiari P, Ceppa P, Fiocca R. The impact of biopsy number and site on the accuracy of intestinal metaplasia detection in the stomach A morphometric study based on virtual biopsies. Dig Liver Dis 2008;40:632-40. [PMID: 18406219 DOI: 10.1016/j.dld.2008.02.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
148 Rugge M, Kim JG, Mahachai V, Miehlke S, Pennelli G, Russo VM, Perng CL, Chang FY, Tandon RK, Singal DK, Sung JJ, Valenzuela JE, Realdi G, Dore MP, Graham DY. OLGA gastritis staging in young adults and country-specific gastric cancer risk. Int J Surg Pathol. 2008;16:150-154. [PMID: 18417671 DOI: 10.1177/1066896907307238] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 1.8] [Reference Citation Analysis]
149 Peleteiro B, Bastos J, Barros H, Lunet N. Systematic review of the prevalence of gastric intestinal metaplasia and its area-level association with smoking. Gaceta Sanitaria 2008;22:236-46. [DOI: 10.1157/13123970] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
150 Eriksson NK, Kärkkäinen PA, Färkkilä MA, Arkkila PE. Prevalence and distribution of gastric intestinal metaplasia and its subtypes. Dig Liver Dis 2008;40:355-60. [PMID: 18291729 DOI: 10.1016/j.dld.2007.12.012] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
151 Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, Moreira-Dias L. We would welcome guidelines for surveillance of patients with gastric atrophic chronic and intestinal metaplasia! Helicobacter 2008;13:75-6. [PMID: 18205670 DOI: 10.1111/j.1523-5378.2008.00589.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
152 Yu J. Chronic injury as a major factor in susceptibility to gastric cancer. Bioscience Hypotheses 2008;1:115-7. [DOI: 10.1016/j.bihy.2008.02.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
153 Sotoudeh M, Derakhshan MH, Abedi-Ardakani B, Nouraie M, Yazdanbod A, Tavangar SM, Mikaeli J, Merat S, Malekzadeh R. Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer. Dig Dis Sci 2008;53:27-33. [PMID: 17492381 DOI: 10.1007/s10620-007-9817-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
154 Annibale B, Lahner E. Assessing the severity of atrophic gastritis. Eur J Gastroenterol Hepatol 2007;19:1059-63. [PMID: 17998829 DOI: 10.1097/MEG.0b013e3282f198c2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
155 De Vries AC, Kuipers EJ. Review article: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 2007;26 Suppl 2:25-35. [PMID: 18081646 DOI: 10.1111/j.1365-2036.2007.03475.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
156 Lauwers GY, Srivastava A. Gastric preneoplastic lesions and epithelial dysplasia. Gastroenterol Clin North Am 2007;36:813-29, vi. [PMID: 17996792 DOI: 10.1016/j.gtc.2007.08.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 68] [Article Influence: 2.4] [Reference Citation Analysis]
157 Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Moreira-Dias L. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia. J Gastroenterol Hepatol 2007;22:1594-604. [PMID: 17845687 DOI: 10.1111/j.1440-1746.2007.04863.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
158 Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, Graham DY. Gastritis staging in clinical practice: the OLGA staging system. Gut 2007;56:631-6. [PMID: 17142647 DOI: 10.1136/gut.2006.106666] [Cited by in Crossref: 282] [Cited by in F6Publishing: 230] [Article Influence: 17.6] [Reference Citation Analysis]
159 Mattioli S, Ruffato A, Di Simone MP, Corti B, D’errico A, Lugaresi ML, Mattioli B, D’ovidio F. Immunopathological Patterns of the Stomach in Adenocarcinoma of the Esophagus, Cardia, and Gastric Antrum: Gastric Profiles in Siewert Type I and II Tumors. The Annals of Thoracic Surgery 2007;83:1814-9. [DOI: 10.1016/j.athoracsur.2007.01.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
160 de Vries AC, Haringsma J, Kuipers EJ. The detection, surveillance and treatment of premalignant gastric lesions related to Helicobacter pylori infection. Helicobacter 2007;12:1-15. [PMID: 17241295 DOI: 10.1111/j.1523-5378.2007.00475.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 4.4] [Reference Citation Analysis]
161 Pérez-grueso Macías MJ, Valle Muñoz J, González De Frutos C, Artaza Varasa T, Rodríguez-merlo R, Alcántara Torres M, Carrobles Jiménez JM. Características clinicopatológicas de la dispepsia no investigada en España. Gastroenterología y Hepatología 2007;30:1-6. [DOI: 10.1157/13097442] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
162 Goetz M, Hoffman A, Galle PR, Neurath MF, Kiesslich R. Confocal laser endoscopy: new approach to the early diagnosis of tumors of the esophagus and stomach. Future Oncol. 2006;2:469-476. [PMID: 16922614 DOI: 10.2217/14796694.2.4.469] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
163 Sekine H, Iijima K, Koike T, Abe Y, Imatani A, Kato K, Ohara S, Shimosegawa T. Regional differences in the recovery of gastric acid secretion after Helicobacter pylori eradication: evaluations with Congo red chromoendoscopy. Gastrointest Endosc 2006;64:678-85. [PMID: 17055856 DOI: 10.1016/j.gie.2006.01.073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
164 Genta RM, Pusztaszeri M. The gastric mucosa in gastric cancer patients in a low-incidence area. Eur J Gastroenterol Hepatol 2006;18:1085-93. [PMID: 16957515 DOI: 10.1097/01.meg.0000231753.58211.05] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
165 Genta RM, Rugge M. Assessing risks for gastric cancer: New tools for pathologists. World J Gastroenterol 2006; 12(35): 5622-5627 [PMID: 17007013 DOI: 10.3748/wjg.v12.i35.5622] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
166 Dinis-Ribeiro M. Chromoendoscopy for early diagnosis of gastric cancer. Eur J Gastroenterol Hepatol 2006;18:831-8. [PMID: 16825898 DOI: 10.1097/00042737-200608000-00005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
167 Genta RM. Assessing the regression of Barrett esophagus: don't try it at home. Adv Anat Pathol 2006;13:127-30. [PMID: 16778476 DOI: 10.1097/00125480-200605000-00004] [Reference Citation Analysis]
168 Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, Qureshi WA, Rajan E, Fanelli R, Wheeler-Harbaugh J, Baron TH, Faigel DO; Standards of Practice Committee, American Society for Gastrointestinal Endoscopy. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006;63:570-80. [PMID: 16564854 DOI: 10.1016/j.gie.2006.02.004] [Cited by in Crossref: 369] [Cited by in F6Publishing: 331] [Article Influence: 21.7] [Reference Citation Analysis]
169 Vogelsang H, Ott K, Mehler J, Keller G, Siewert JR. [Prophylactic gastric surgery]. Chirurg 2005;76:1115-24. [PMID: 16292563 DOI: 10.1007/s00104-005-1119-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
170 Shiotani A, Iishi H, Uedo N, Kumamoto M, Nakae Y, Ishiguro S, Tatsuta M, Graham DY. Histologic and serum risk markers for noncardia early gastric cancer. Int J Cancer. 2005;115:463-469. [PMID: 15688378 DOI: 10.1002/ijc.20852] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 2.9] [Reference Citation Analysis]
171 Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol. 2005;36:228-233. [PMID: 15791566 DOI: 10.1016/j.humpath.2004.12.008] [Cited by in Crossref: 152] [Cited by in F6Publishing: 164] [Article Influence: 8.4] [Reference Citation Analysis]
172 Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005;25:197-222. [PMID: 15749238 DOI: 10.1016/j.cll.2004.12.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
173 Dinis-Ribeiro M, da Costa-Pereira A, Lopes C, Barbosa J, Guilherme M, Moreira-Dias L, Lomba-Viana H, Silva R, Abreu N, Lomba-Viana R. Validity of serum pepsinogen I/II ratio for the diagnosis of gastric epithelial dysplasia and intestinal metaplasia during the follow-up of patients at risk for intestinal-type gastric adenocarcinoma. Neoplasia 2004;6:449-56. [PMID: 15548353 DOI: 10.1593/neo.03505] [Cited by in Crossref: 48] [Cited by in F6Publishing: 54] [Article Influence: 2.7] [Reference Citation Analysis]
174 Marshall BJ, Windsor HM. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Med Clin North Am. 2005;89:313-344, viii. [PMID: 15656929 DOI: 10.1016/j.mcna.2004.09.001] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 5.3] [Reference Citation Analysis]
175 Nardone G. 16 Role of Helicobacter pylori in Gastric Cancer. Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma 2005. [DOI: 10.1016/s1874-5784(05)80078-9] [Reference Citation Analysis]
176 Charvet I, Ory G, Thueler P, Brundler MA, Saint-Ghislain M, Azarpey N, Hadengue A, Depeursinge C, Vermeulen B, Meda P. Diagnosis and grading of gastritis by non-invasive optical analysis. Eur J Gastroenterol Hepatol 2004;16:1189-98. [PMID: 15489581 DOI: 10.1097/00042737-200411000-00018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
177 Derakhshan MH, Yazdanbod A, Sadjadi AR, Shokoohi B, McColl KE, Malekzadeh R. High incidence of adenocarcinoma arising from the right side of the gastric cardia in NW Iran. Gut 2004;53:1262-6. [PMID: 15306582 DOI: 10.1136/gut.2003.035857] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 1.7] [Reference Citation Analysis]
178 Nardone G, Rocco A, Malfertheiner P. Review article: helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004;20:261-70. [PMID: 15274662 DOI: 10.1111/j.1365-2036.2004.02075.x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 5.0] [Reference Citation Analysis]
179 Delchier JC. [How to prevent precancerous gastric lesions]. Gastroenterol Clin Biol 2004;28:D172-7. [PMID: 15213677 DOI: 10.1016/s0399-8320(04)95001-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
180 Walker MM. Biopsy assessment of drug efficacy in the gastrointestinal tract. Br J Clin Pharmacol 2003;56:483-8. [PMID: 14651720 DOI: 10.1046/j.1365-2125.2003.01981.x] [Reference Citation Analysis]
181 Rugge M, Russo VM, Guido M. Review article: what have we learnt from gastric biopsy? Aliment Pharmacol Ther 2003;17 Suppl 2:68-74. [PMID: 12786616 DOI: 10.1046/j.1365-2036.17.s2.15.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
182 Lauwers GY. Defining the pathologic diagnosis of metaplasia, atrophy, dysplasia, and gastric adenocarcinoma. J Clin Gastroenterol 2003;36:S37-43; discussion S61-2. [PMID: 12702964 DOI: 10.1097/00004836-200305001-00007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
183 Sepulveda AR, Graham DY. Role of Helicobacter pylori in gastric carcinogenesis. Hematology/Oncology Clinics of North America 2003;17:505-523. [DOI: 10.1016/s0889-8588(03)00021-2] [Reference Citation Analysis]
184 Walker MM. Is intestinal metaplasia of the stomach reversible? Gut 2003;52:1-4. [PMID: 12477745 DOI: 10.1136/gut.52.1.1] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
185 Li L, Genta RM, Go MF, Gutierrez O, Kim JG, Graham DY. Helicobacter pylori strain and the pattern of gastritis among first-degree relatives of patients with gastric carcinoma. Helicobacter 2002;7:349-55. [PMID: 12485121 DOI: 10.1046/j.1523-5378.2002.00108.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
186 Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 2002;16:1209-16. [PMID: 12144569 DOI: 10.1046/j.1365-2036.2002.01300.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 5.0] [Reference Citation Analysis]
187 Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, Leandro G, Price AB, Sipponen P, Solcia E, Watanabe H, Genta RM. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249-59. [PMID: 12144574 DOI: 10.1046/j.1365-2036.2002.01301.x] [Cited by in Crossref: 242] [Cited by in F6Publishing: 182] [Article Influence: 11.5] [Reference Citation Analysis]
188 Sepulveda AR, Graham DY. Role of Helicobacter pylori in gastric carcinogenesis. Gastroenterol Clin North Am 2002;31:517-35, x. [PMID: 12134616 DOI: 10.1016/s0889-8553(02)00012-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 2.1] [Reference Citation Analysis]
189 Sepulveda A, Peterson LE, Shelton J, Gutierrez O, Graham DY. Histological patterns of gastritis in H. pylori-infected individuals with a family history of gastric cancer. Am J Gastroenterol 2002;97:1365-70. [PMID: 12094851 DOI: 10.1111/j.1572-0241.2002.05667.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
190 Rugge M, Russo V, Busatto G, Genta RM, Di Mario F, Farinati F, Graham DY. The phenotype of gastric mucosa coexisting with Barrett's oesophagus. J Clin Pathol 2001;54:456-60. [PMID: 11376019 DOI: 10.1136/jcp.54.6.456] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
191 Genta RM, Rugge M. Review article: pre-neoplastic states of the gastric mucosa--a practical approach for the perplexed clinician. Aliment Pharmacol Ther 2001;15 Suppl 1:43-50. [PMID: 11488661 DOI: 10.1046/j.1365-2036.2001.00110.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
192 Sepulveda AR. Molecular testing of Helicobacter pylori-associated chronic gastritis and premalignant gastric lesions: clinical implications. J Clin Gastroenterol 2001;32:377-82. [PMID: 11319306 DOI: 10.1097/00004836-200105000-00004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]